SCHEMBL1473973

SCHEMBL1473973

NC(=S)NC1CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2257067 0.88 — —
SCHEMBL1475935 0.88 — —
SCHEMBL27720256 0.87 EPHX1 (0.47) —
SCHEMBL16109065 0.87 EPHX1 (0.47) —
SCHEMBL8739516 0.86 ALDH1A1 (0.64) —
SCHEMBL1605115 0.86 ALDH1A1 (0.64) —
SCHEMBL1605352 0.86 ALDH1A1 (0.64) —
SCHEMBL1528011 0.86 ALDH1A1 (0.64) —
SCHEMBL17451776 0.85 KMT2A (0.47) —
SCHEMBL5131730 0.85 SMN1; SMN2 (0.39) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 121 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004101552-A1 OXAZOLIDINONE DERIVATIVES AS ANTIBACTERIAL AGENTS ORCHID CHEMICALS & PHARMACEUTICALS LTD (IN) 2004-11-25 — — WO claimed
US-20030055261-A1 Compounds with growth hormone releasing properties HELSINN THERAPEUTICS (U.S.), INC. 2003-03-20 — — US claimed
US-20030040483-A1 Compounds with growth hormone releasing properties HELSINN THERAPEUTICS (U.S.), INC. 2003-02-27 — — US claimed
US-6127391-A A PEPTIDE MIMETIC COMPOUND FOR STIMULATING THE RELEASE OF GROWTH HORMONE FROM THE PITUITARY NOVO NORDISK A/S (DK) 2000-10-03 — — US claimed
EP-0869974-A1 COMPOUNDS WITH GROWTH HORMONE RELEASING PROPERTIES NOVO NORDISK A/S (DK) 1998-10-14 — — EP claimed
WO-1997023508-A1 COMPOUNDS WITH GROWTH HORMONE RELEASING PROPERTIES NOVO NORDISK A/S (DK) 1997-07-03 — — WO claimed
US-20250206730-A1 THIAZOLE DERIVATIVE COMPOUND AND USES THEREOF AUTOTELIC BIO INC. (KR) 2025-06-26 — — US disclosed
WO-2025063816-A1 COMPOSITION FOR TREATING UTERINE FIBROSIS COMPRISING THIAZOLE DERIVATIVE COMPOUND 오토텔릭바이오 주식회사 2025-03-27 — — WO disclosed
WO-2025063819-A1 COMPOSITION FOR TREATING FIBROTIC DISEASE COMPRISING THIAZOLE DERIVATIVE COMPOUND 오토텔릭바이오 주식회사 2025-03-27 — — WO disclosed
WO-2025063820-A1 COMPOSITION FOR TREATING PULMONARY FIBROSIS COMPRISING THIAZOLE DERIVATIVE COMPOUND 오토텔릭바이오 주식회사 2025-03-27 — — WO disclosed
CN-112028825-B Tyrosine kinase inhibitor and pharmaceutical composition containing same 广东众生睿创生物科技有限公司 2025-03-14 — — CN disclosed
EP-4501928-A1 THIAZOLE DERIVATIVE COMPOUND AND USES THEREOF Autotelic Bio Inc. (KR) 2025-02-05 — — EP disclosed
CN-119255993-A Thiazole derivative compound and use thereof 奥托泰利克生物公司 2025-01-03 — — CN disclosed
EP-0397511-B1 Novel cephalosporin compounds and processes for preparation thereof LUCKY LTD (KR) 1996-09-04 — — EP disclosed
US-5541229-A ANGIOITENSIN II ANTAGONIST AS HYPOTENSIVE AGENTS, ANTIISCHEMIC AGENTS AND CARDIOVASCULAR DISORDERS DR. KARL THOMAE GMBH (DE) 1996-07-30 — — US disclosed
US-5318992-A Administering for the treatment of hypotensive conditions and shock MERRELL DOW PHARMACEUTICALS INC. (US) 1994-06-07 — — US disclosed
US-5202315-A Antiboiotic LUCKY, LTD. (KR) 1993-04-13 — — US disclosed
WO-1992008721-A1 NOVEL CEPHALOSPORIN COMPOUNDS AND PROCESSES FOR PREPARATION THEREOF LUCKY, LTD. (KR) 1992-05-29 — — WO disclosed
EP-0446699-A1 Inhibitors of nitric oxide biosynthesis MERRELL PHARMACEUTICALS INC. (US) 1991-09-18 — — EP disclosed
EP-0397511-A2 Novel cephalosporin compounds and processes for preparation thereof LUCKY, LTD. (KR) 1990-11-14 — — EP disclosed
Send feedback